UBS takes a shine to a pair of tobacco names, raising its price target on buy-rated Altria (MO...

UBS takes a shine to a pair of tobacco names, raising its price target on buy-rated Altria (MO+0.1%) and Lorillard (LO-0.7%). Despite a strong run that has seen the duo outperform consumer staples by a healthy margin in 2012, analyst Nik Modu says strong sector rotation, low interest rates, and favorable pricing remains in play.